Inventor
YEH WEN-CHEN
US20 patents
⚠️ This page may combine multiple inventors who share the name “YEH WEN-CHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
12 patentsUS10221162B2Mar 5, 2019
Triazole agonists of the APJ receptor
AMGEN INC12 citations92
US10058550B2Aug 28, 2018
Methods of treating heart failure
AMGEN INC13 citations92
US9868721B2Jan 16, 2018
Triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9745286B2Aug 29, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9573936B2Feb 21, 2017
Triazole agonists of the APJ receptor
AMGEN INC19 citations92
US9988369B2Jun 5, 2018
Heterocyclic triazole compounds as agonists of the APJ receptor
AMGEN INC8 citations83
US11046680B1Jun 29, 2021
Heteroaryl-substituted triazoles as APJ receptor agonists
AMGEN INC2 citations62
US10906890B2Feb 2, 2021
Triazole phenyl compounds as agonists of the APJ receptor
AMGEN INC1 citations62
US10736883B2Aug 11, 2020
Triazole furan compounds as agonists of the APJ receptor
AMGEN INC1 citations62
US11020395B2Jun 1, 2021
Cycloalkyl substituted triazole compounds as agonists of the APJ receptor
AMGEN INC1 citations61
US11191762B2Dec 7, 2021
Alkyl substituted triazole compounds as agonists of the APJ Receptor
AMGEN INC0 citations51
US9850297B2Dec 26, 2017
Secreted frizzle-related protein 5 (SFRP5) binding proteins
AMGEN INC0 citations44
SURROZEN OPERATING INC
7 patentsUS12006368B2Jun 11, 2024
Anti-frizzled antibodies and methods of use
SURROZEN OPERATING INC3 citations69
US11958891B2Apr 16, 2024
Tissue-specific Wnt signal enhancing molecules and uses thereof
SURROZEN OPERATING INC2 citations67
US12240876B2Mar 4, 2025
Liver-specific Wnt signal enhancing molecules and uses thereof
SURROZEN OPERATING INC1 citations61
US11746150B2Sep 5, 2023
Anti-LRP5/6 antibodies and methods of use
SURROZEN OPERATING INC1 citations58
US12297278B2May 13, 2025
Wnt surrogate molecules and uses thereof
SURROZEN OPERATING INC0 citations56
US11773171B2Oct 3, 2023
WNT surrogate molecules and uses thereof
SURROZEN OPERATING INC1 citations56
US12466884B2Nov 11, 2025
Tissue-specific WNT signal enhancing molecules and uses
SURROZEN OPERATING INC0 citations47